We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.00 | 0.77% | 260.80 | 260.40 | 260.60 | 266.40 | 255.80 | 263.20 | 3,596,311 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 41.01 | 5.35B |
TIDMCTEC
RNS Number : 3272M
ConvaTec Group PLC
07 May 2020
ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2020 - Poll Result
ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today ("Meeting"), The results of the poll held in relation to the resolutions proposed at the Meeting are set out below.
For Against Total Votes % of Number (see note 2) (see note 2) ISC of Votes Voted Withheld (see note 3 Resolution No of shares % No of Shares % -------------- ------- ------------- ------ Receive Annual Report and 1 Accounts 1,689,253,478 99.99 162,424 0.01 1,689,415,902 85.17 1,375,861 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Approve the Directors' Remuneration 2 Report 1,459,271,427 86.35 230,658,135 13.65 1,689,929,562 85.20 908,684 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Approve the Directors' Remuneration 3 Policy 1,479,320,219 87.54 210,611,343 12.46 1,689,931,562 85.20 906,684 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Declare Final 4 Dividend 1,670,311,992 98.79 20,526,249 1.21 1,690,838,241 85.24 6 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Elect John McAdam as 5 a director 1,686,038,868 99.72 4,725,844 0.28 1,690,764,712 85.24 73,534 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Elect Karim Bitar as 6 a director 1,687,089,831 99.78 3,746,388 0.22 1,690,836,219 85.24 2,028 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Elect Brian May as a 7 director 1,689,080,374 99.90 1,749,450 0.10 1,690,829,824 85.24 8,423 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Frank Schulkes 8 as a director 1,684,095,328 99.60 6,734,291 0.40 1,690,829,619 85.24 8,628 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Margaret Ewing as 9 a director 1,662,219,417 98.31 28,611,702 1.69 1,690,831,119 85.24 7,128 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Rick Anderson 10 as a director 1,686,272,799 99.73 4,561,920 0.27 1,690,834,719 85.24 3,528 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Regina Benjamin 11 as a director 1,678,521,751 99.30 11,891,727 0.70 1,690,413,478 85.22 424,768 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Ros Rivaz 12 as a director 1,630,402,633 96.47 59,672,747 3.53 1,690,075,380 85.21 762,866 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-elect Sten Scheibye 13 as a director 1,687,084,151 99.78 3,745,468 0.22 1,690,829,619 85.24 8,628 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Re-appoint Deloitte 14 LLP as auditor 1,690,827,240 100.00 9,746 0.00 1,690,836,986 85.24 1,261 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Authorise the directors to determine the remuneration of the Company's 15 auditor 1,690,692,456 100.00 5,000 0.00 1,690,697,456 85.24 140,791 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Authorise political donations and political 16 expenditure 1,679,778,558 99.35 11,050,957 0.65 1,690,829,515 85.24 8,732 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Authorise allotment 17 of shares 1,576,731,448 93.28 113,598,212 6.72 1,690,329,660 85.22 508,587 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Disapply pre-emption 18 rights* 1,665,615,258 98.53 24,844,432 1.47 1,690,459,690 85.23 378,557 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Disapply pre-emption rights in connection with an acquisition or specified 19 capital investment* 1,664,010,440 98.44 26,449,249 1.56 1,690,459,689 85.23 378,557 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Authorise purchase 20 of own shares* 1,669,151,425 98.76 20,937,729 1.24 1,690,089,154 85.21 749,092 --------------------- -------------- ------- ------------- ------ -------------- ------- ----------- Call general meetings on 14 days' 21 notice* 1,663,148,185 98.36 27,687,156 1.64 1,690,835,341 85.24 2,906 --------------------- -------------- ------- ------------- ------ -------------- ------- -----------
*Special Resolution
NOTES:
1. All resolutions were passed. 2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 6 May 2020 was 1,983,513,851 shares; 85.24% of voting capital was instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGUBAVRRRUVRAR
(END) Dow Jones Newswires
May 07, 2020 11:15 ET (15:15 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions